Why Inovio Pharmaceuticals Is a Top Stock to Watch Amid the Coronavirus Pandemic

Why Inovio Pharmaceuticals Is a Top Stock to Watch Amid the Coronavirus Pandemic

Are three reasons why Inovio remains a top coronavirus stock to watch.. The company's INO-4800 is in the thick of the COVID-19 vaccine race.. CEPI previously gave Inovio a grant of up to $56 million to develop vaccines for Lassa fever and MERS.. On Thursday, Inovio announced the Bill & Melinda Gates Foundation had awarded a $5 million grant to speed up the testing of its Cellectra 3PSP device for intradermal delivery of its COVID-19 vaccine.. Inovio anticipates reporting results from its Reveal 1 late-stage clinical study evaluating the drug in treating cervical HSIL by the fourth quarter of 2020.. Cumulative Growth of a $10,000 Investment in Stock Advisor Calculated by Time-Weighted Return.